Illumina, Inc. (BVMF:I1LM34)

Market Cap	103.68B
Revenue (ttm)	22.91B
Net Income (ttm)	3.76B
Shares Out	n/a
EPS (ttm)	23.83
PE Ratio	27.61
Forward PE	25.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195
Average Volume	162
Open	138.40
Previous Close	138.35
Day's Range	138.40 - 139.29
52-Week Range	83.58 - 176.58
Beta	1.45
RSI	67.81
Earnings Date	Feb 6, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 9,030
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: I1LM34

Financial Performance

In 2024, Illumina's revenue was $4.37 billion, a decrease of -2.93% compared to the previous year's $4.50 billion. Losses were -$1.22 billion, 5.34% more than in 2023.

Financial numbers in USD